News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Athersys, Inc. and Fast Forward, LLC Enter Collaboration to Support Development of MultiStem to Treat Multiple Sclerosis


10/21/2011 10:27:57 AM

CLEVELAND and NEW YORK, Oct. 21, 2011 (GLOBE NEWSWIRE) -- Athersys, Inc. (Nasdaq:ATHX) and Fast Forward, LLC, a nonprofit subsidiary of the National Multiple Sclerosis Society, announced today an alliance to fund the development of Athersys' MultiStem® adult stem cell platform for the treatment of Multiple Sclerosis (MS), including treatment of chronic progressive forms of the disease, with the goal of accelerating the clinical application of MultiStem for patients diagnosed with MS. Fast Forward will commit up to $640,000 to fund the advancement of the program to clinical development stage.

Read at GlobeNewswire

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES